ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer’s Disease

| Source: ProMIS Neurosciences Inc. ProMIS Neurosciences Inc.

TORONTO and CAMBRIDGE, Mass., Sept. 19, 2017 (GLOBE NEWSWIRE) -- ERN UK